Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.

Yule AM, Martelon M, Faraone SV, Carrellas N, Wilens TE, Biederman J.

J Psychiatr Res. 2017 Feb;85:49-55. doi: 10.1016/j.jpsychires.2016.10.018.

PMID:
27835739
2.

Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

Molina BS, Pelham WE Jr.

Annu Rev Clin Psychol. 2014;10:607-39. doi: 10.1146/annurev-clinpsy-032813-153722. Review.

3.

The genetics of attention deficit/hyperactivity disorder in adults, a review.

Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, Mick E, Grevet EH, Johansson S, Haavik J, Lesch KP, Cormand B, Reif A; International Multicentre persistent ADHD CollaboraTion..

Mol Psychiatry. 2012 Oct;17(10):960-87. doi: 10.1038/mp.2011.138. Review.

4.

A study of prevalence and pattern of hyperactive syndrome in primary school children.

Chawla PL, Sahasi G, Sundaram KR, Mehta M.

Indian J Psychiatry. 1981 Oct;23(4):313-23.

5.

Attention deficit hyperactivity disorder and blood lead levels in Chinese children.

Brondum J.

Environ Health Perspect. 2009 Jul;117(7):A286. doi: 10.1289/ehp.0900850. No abstract available.

6.

Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.

Biederman J, Petty CR, Monuteaux MC, Mick E, Clarke A, Ten Haagen K, Faraone SV.

J Child Psychol Psychiatry. 2009 Mar;50(3):352-8. doi: 10.1111/j.1469-7610.2008.02040.x.

7.

Attention-deficit-hyperactivity disorder and reward deficiency syndrome.

Blum K, Chen AL, Braverman ER, Comings DE, Chen TJ, Arcuri V, Blum SH, Downs BW, Waite RL, Notaro A, Lubar J, Williams L, Prihoda TJ, Palomo T, Oscar-Berman M.

Neuropsychiatr Dis Treat. 2008 Oct;4(5):893-918.

8.

Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.

Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, Saha TD, Smith SM, Pulay AJ, Pickering RP, Ruan WJ, Compton WM.

Mol Psychiatry. 2009 Nov;14(11):1051-66. doi: 10.1038/mp.2008.41.

9.

The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.

Adesman AR.

Prim Care Companion J Clin Psychiatry. 2001 Apr;3(2):66-77.

10.

Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review.

Hechtman L.

J Psychiatry Neurosci. 1994 May;19(3):193-201. Review.

11.

Association of attention-deficit disorder and the dopamine transporter gene.

Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL.

Am J Hum Genet. 1995 Apr;56(4):993-8.

12.

Artificial food colors and childhood behavior disorders.

Silbergeld EK, Anderson SM.

Bull N Y Acad Med. 1982 Apr;58(3):275-95. Review. No abstract available.

14.

Presidential address: the genetics of human behavior--lessons for two societies.

Comings DE.

Am J Hum Genet. 1989 Apr;44(4):452-60. No abstract available.

15.

Cognitive impairments in abstinent alcoholics.

Fein G, Bachman L, Fisher S, Davenport L.

West J Med. 1990 May;152(5):531-7. Review.

16.

The varied adult psychopathologies of children's behavior disorders.

Huessy HR.

J Psychiatry Neurosci. 1992 Oct;17(4):146-57. Review.

17.

Adoption and children with learning and behavior problems.

Taichert LC, Harvin DD.

West J Med. 1975 Jun;122(6):464-70.

Supplemental Content

Support Center